CD28 T-cell costimulatory molecule expression in pemphigus vulgaris

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 3, 2009, Pages 288-291

  Alecu, M ^a   Ursaciuc, C ^b   Surcel, M ^b   Coman, G ^a   Ciotaru, D ^b   Dobre, M ^b  

^a 'Scarlat Longhin' Clinic of Dermatology   (Romania)

^b VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

Author keywords

Autoimmune diseases; CD28 molecule; Pemphigus vulgaris; Regulatory T cells

Indexed keywords

CD28 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; MALE; MOLECULE; NATURAL KILLER CELL; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIGENS, CD28; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; T-LYMPHOCYTES;

EID: 60049089385     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.03035.x     Document Type: Article

References (19)

1. Stanley JR. Pemphigus. In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, eds. Fitzpatrik's Dermatology in General Medicine, 6th edn. McGraw-Hill, New York, 2003 : 558 567.
2. Hertl M. Humoral and cellular autoimmunity in autoimmune bullous disorders. Int Arch Allergy Immunol 2000 122 : 91 100.
3. Hertl M, Eming R, Veldman C. T cell control in autoimmune bullous skin disorders. J Clin Invest 2006 116 : 1159 1166.
4. Veldman C, Pahl A, Beissert S et al. Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type I regulatory T cell into Th2-like cells. J Immunol 2006 176 : 3215 3222.
5. Okazaki T, Iwai Y, Honjo T. New regulatory co-receptors. inducible co-stimulator and PD-1. Curr Opin Immunol 2002 14 : 779 782.
6. Greenwald RJ, Latchman YE, Sharpe AH. Negative co-receptor on lymphocytes. Curr Opin Immunol 2002 14 : 391 396.
7. + regulatory T cells. J Immunol 2003 171 : 3348 3352.
8. Kawamoto M, Harigai M, Hara M et al. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon gamma and anti double stranded DNA antibody production. Arthritis Res Ther 2006 8 : 3/ R62.
9. Hu S, Tao D, He P. Expression of costimulatory molecules B7/CD28 in systemic lupus erythematosus. J Huazhong University Sci Technol 2006 24 : 245 265.
10. Bour-Jordan H, Blueston JA. CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol 2002 22 : 1 7.
11. Alegre ML, Fallarino F. Mechanisms of CTLA-4-Ig in tolerance induction. Curr Pharm Des 2006 12 : 149 160.
12. Buhlmann JE, Elkin SK, Sharpe AH. A role for the B7-1/B7-2: CD28/CTLA-4 pathway during negative selection. J Immunol 2003 170 : 5421 5428.
13. Gao JX, Zhang H, Bai XF et al. Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells. J Exp Med 2002 195 : 959 971.
14. Bohl KC, Rojas AI, Khan IU, Ahmed AR. Presence of IL-10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid. Cytokine 2000 12 : 1076 1083.
15. Eberhard Y, Burgos E, Gaglliardi J et al. Cytokine polymorphisms in patients with pemphigus. Arch Dermatol Res 2005 296 : 309 313.
16. Takahashi H, Amagai M, Nishikawa T, Fujii Y, Kawakami Y, Kuwana M. Novel system evaluating in vivo pathogenity of desmoglein 3-reactive T cell clones, using murine pemphigus vulgaris. J Immunol 2008 181 : 1526 1535.
17. + T suppressor lymphocytes. Clin Exp Med 2004 4 : 86 92.
18. - cells in newly remittent patients with pemphigus vulgaris. J Invest Dermatol 2004 125 : 1084 A.
19. Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood 2005 105 : 13 21.